Wechselwirkungen · Clopidogrel Krka d.d. (previously Zopya)
Clopidogrel Krka d.d. 75 mg film-coated tablets · Abschnitt 4.5 · PDF-Seite 7–8
HOS-212166 · Präparat HOS-154840
7 A significantly reduced platelet inhibition has been shown in HIV patients treated with ritonavir-or cobicistat-boosted ART. Although the clinical relevance of these findings is uncertain, there have been spontaneous reports of HIV-infected patients treated with ritonavir boosted ART, who have experienced re-occlusive events after de-obstruction or have suffered thrombotic events under a clopidogrel loading treatment schedule. Average platelet inhibition can be decreased with concomitant use of clopidogrel and ritonavir. Therefore, concomitant use of clopidogrel with ART boosted therapies should be discouraged.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
RxNorm-Namen im Text (wörtliche Treffer, Rolle nicht bewertet): clopidogrel (HOS-087927) ritonavir (HOS-084521)
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-05-13T12:00:00Z · SHA-256 38319568b52a779a4ed92c9d4481ec0fa339af9002213bb9c72643f9947622a1 · Passage 2edaca175f263a84bb6c319ce3674fdd50517af98a9f5f2e174782e0fbd867a9 · Zeichen 6012–6633 im Abschnitt